AZN

AstraZeneca PLC (NASDAQ:AZN) is a British-Swedish multinational biopharmaceutical company founded in 1999 through the merger of Astra AB of Sweden and Zeneca Group PLC of the United Kingdom. The company traces its roots back to 1992 when Zeneca was incorporated, with the current entity emerging from the strategic combination that created one of the world's largest pharmaceutical companies. Headquartered in Cambridge, United Kingdom, AstraZeneca has evolved into a global leader in prescription medicines, focusing on innovative treatments across oncology, cardiovascular, respiratory, and rare diseases. The company operates through a network of 31 manufacturing sites worldwide and maintains strategic research and development centers across multiple continents, serving healthcare providers and patients in over 100 countries.